| ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids (NCT05629702) | University of Birmingham | 2023-02-03 |
| Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer (NCT05601505) | Peking Union Medical College Hospital | 2023-02-03 |
| Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL) (NCT05747261) | Biocad | 2023-02-02 |
| Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients (NCT05722977) | Peking Union Medical College Hospital | 2023-02-02 |
| Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer (NCT05880485) | Peking Union Medical College Hospital | 2023-02-02 |
| A Randomized Controlled Trial of a Digital, Self-testing Strategy for COVID-19 Infection in South Africa. (NCT05436795) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2023-02-02 |
| Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. (NCT05575505) | Tanta University | 2023-02-02 |
| Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis (NCT04789850) | Assistance Publique - Hôpitaux de Paris | 2023-02-02 |
| Bolus vs. Continuous IV Lidocaine Against Post-Extubation Cough in Post-Thyroidectomy Patients (NCT06040034) | Universitas Padjadjaran | 2023-02-02 |
| Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma (NCT05428007) | NYU Langone Health | 2023-02-02 |
| Effects of Rifaximin on Gut Microbiota and Emotion (NCT05587036) | Universitaire Ziekenhuizen KU Leuven | 2023-02-02 |
| Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus (NCT06040177) | First Affiliated Hospital of Guangxi Medical University | 2023-02-02 |
| Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (NCT05502315) | Rana McKay, MD | 2023-02-02 |
| Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone (NCT05282550) | Johns Hopkins University | 2023-02-02 |
| Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers (NCT05395624) | Ashvattha Therapeutics, Inc. | 2023-02-02 |
| Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB (NCT05295212) | Hunan Province Tumor Hospital | 2023-02-01 |
| Clinical Study on the Efficacy and Safety of Qingre Heji in the Treatment of Acute Upper Respiratory Tract Infection (NCT06520618) | Shengjing Hospital | 2023-02-01 |
| Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations (NCT05498272) | Rana McKay, MD | 2023-02-01 |
| A Study to Evaluate the Efficacy and Safety of HLX07 in nsqNSCLC Patients With High EGFR Expression (NCT05215925) | Shanghai Henlius Biotech | 2023-02-01 |
| A Herbal Compound for Psoriasis (NCT06301997) | Fasa University of Medical Sciences | 2023-02-01 |
| BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer (NCT05715398) | Shanghai Gopherwood Biotech Co., Ltd. | 2023-02-01 |
| Immunotherapy in Patients With Early dMMR Rectal Cancer (NCT05732389) | Odense University Hospital | 2023-02-01 |
| Lazertinib 160mg in EGFR T790M NSCLC (NCT05701384) | Samsung Medical Center | 2023-02-01 |
| Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease (NCT04482413) | Nature Cell Co. Ltd. | 2023-02-01 |
| Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial (NCT05327686) | NRG Oncology | 2023-02-01 |
| Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis (NCT05719311) | Entero Therapeutics | 2023-02-01 |
| Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia (NCT05870995) | Shanghai Jiao Tong University School of Medicine | 2023-02-01 |
| Vitamin D and Polycystic Ovarian Syndrome (PCOS) (NCT03989778) | Aga Khan University | 2023-02-01 |
| Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer (NCT05669586) | Affiliated Hospital of Jiangnan University | 2023-02-01 |
| Study of HS-10517 in Chinese Adult Participants (NCT05779579) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-02-01 |
| Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) (NCT05599789) | Peking Union Medical College Hospital | 2023-02-01 |
| Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea (NCT05719896) | Centre of Clinical Pharmacology, Hanoi Medical University | 2023-02-01 |
| Gene and Protein Expression Profiles After Treatment of Actinic Keratoses (NCT05740969) | Ismail Gögenur | 2023-02-01 |
| Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma (NCT05472948) | Sun Yat-sen University | 2023-02-01 |
| Managing Dentine Hypersensitivity With Silver Diamine Fluoride on Older Adults (NCT05392868) | The University of Hong Kong | 2023-02-01 |
| Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma (NCT05308225) | Sorrento Therapeutics, Inc. | 2023-02-01 |
| A Novel Alloplastic Patient Specific Temporalis Tendon Enthesis (NCT06770868) | Alexandria University | 2023-02-01 |
| Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia (NCT05918198) | Peking University People's Hospital | 2023-02-01 |
| Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS (NCT05694130) | Peking Union Medical College Hospital | 2023-02-01 |
| Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer (NCT07014410) | Zhejiang Cancer Hospital | 2023-02-01 |
| Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer (NCT05445648) | First Affiliated Hospital Xi'an Jiaotong University | 2023-02-01 |
| Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold (NCT05763329) | Chulalongkorn University | 2023-02-01 |
| PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer (NCT05759546) | Fudan University | 2023-02-01 |
| The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention (NCT06319469) | Beni-Suef University | 2023-02-01 |
| Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA (NCT05667662) | Pulmatrix Inc. | 2023-02-01 |
| Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors (NCT05768464) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2023-02-01 |
| Hyaluronic Acid in Overuse Knee Pain (NCT05450458) | Hospital Regional Tlalnepantla | 2023-02-01 |
| Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults (NCT04824872) | Zealand Pharma | 2023-02-01 |
| Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis (NCT05567068) | Tanta University | 2023-02-01 |
| Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma (NCT05694416) | Zhongnan Hospital | 2023-02-01 |
| Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis (NCT05722548) | Shanghai Jiao Tong University School of Medicine | 2023-02-01 |
| Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain (NCT04930887) | Stanford University | 2023-02-01 |
| A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT05613088) | Bristol-Myers Squibb | 2023-02-01 |
| Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT (NCT06061848) | Lars Olaf Cardell | 2023-02-01 |
| Tacrolimus for Thrombocytopenia in SS (NCT05678335) | Peking Union Medical College Hospital | 2023-02-01 |
| CISH Inactivated TILs in the Treatment of NSCLC (NCT05566223) | Intima Bioscience, Inc. | 2023-02-01 |
| Limonene for Pulmonary Nodule Chemoprevention (NCT05525260) | Shanghai Jiao Tong University School of Medicine | 2023-02-01 |
| Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer (NCT05759572) | Fudan University | 2023-02-01 |
| Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer (NCT06455072) | Fujian Cancer Hospital | 2023-02-01 |
| Melatonin for Treatment of Delirium in Critically Ill Adult Patients (NCT05713877) | Ciusss de L'Est de l'Île de Montréal | 2023-02-01 |
| Drospirenone-only Pill as Emergency Contraception (NCT05675644) | University of Colorado, Denver | 2023-02-01 |
| A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML (NCT05541549) | Cellevolve Bio Inc | 2023-02-01 |
| Efficacy and Safety of Escócia Association in the Treatment of Acute Pain (NCT04666701) | EMS | 2023-02-01 |
| Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma (NCT05745181) | The Affiliated Hospital of Xuzhou Medical University | 2023-02-01 |
| Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia (NCT05807347) | Hematology department of the 920th hospital | 2023-02-01 |
| Efficacy of Adding Low Dose Ketamine or Fentanyl to Propofol-dexmedetomidine as Total Intravenous Anesthesia (NCT06031883) | Minia University | 2023-02-01 |
| Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer (NCT06241105) | Peking Union Medical College Hospital | 2023-02-01 |
| Assessment of Photodynamic Therapy With Annatto and Led for the Treatment of Halitosis in Mouth-Breathing Children (NCT05590897) | University of Nove de Julho | 2023-02-01 |
| Best Solution Identification to Prevent Hyperchloremia Combinations of Sodium Chloride and Sodium Acetate IV Fluids Along With Standard of Care Treatment in Acute Stroke Patients (NCT05869565) | Aga Khan University | 2023-02-01 |
| Efficacy Assessment of Chinese Herbal Medicine Tangweian Recipe Treating Participants With Diabetic Gastroenteropathy (NCT05720442) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2023-02-01 |
| Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma (NCT05656144) | Peking University Cancer Hospital & Institute | 2023-02-01 |
| Potential of Moderate Whole Body Hyperthermia to Enhance Response (NCT05821166) | Charite University, Berlin, Germany | 2023-02-01 |
| Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome (NCT05597800) | Universita di Verona | 2023-02-01 |
| Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma (NCT05664139) | Fujian Cancer Hospital | 2023-02-01 |
| Efficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction (NCT05918419) | Peking Union Medical College Hospital | 2023-02-01 |
| Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) (NCT05705700) | Masonic Cancer Center, University of Minnesota | 2023-02-01 |
| Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer (NCT05775900) | Sun Yat-sen University | 2023-02-01 |
| Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer. (NCT05749575) | Sun Yat-sen University | 2023-02-01 |
| Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients (NCT05664906) | Chinese University of Hong Kong | 2023-01-31 |
| VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA) (NCT05715125) | Ventyx Biosciences, Inc | 2023-01-31 |
| Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. (NCT05563467) | Maria Sklodowska-Curie National Research Institute of Oncology | 2023-01-31 |
| Signal TrAnsduction Pathway Activity Analysis in OVarian cancER (NCT03458221) | Gynaecologisch Oncologisch Centrum Zuid | 2023-01-31 |
| PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma (NCT05430698) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-01-31 |
| Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia (NCT05677919) | Mayo Clinic | 2023-01-31 |
| 101-PGC-005 for the Treatment of COVID-19 (NCT05656521) | 101 Therapeutics | 2023-01-31 |
| Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis (NCT04854096) | NS Pharma, Inc. | 2023-01-31 |
| Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children (NCT05708391) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2023-01-31 |
| A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia (NCT05520567) | Astellas Pharma Global Development, Inc. | 2023-01-31 |
| Mesenchymal Stem Cells for Age-Related Frailty (NCT05284604) | VA Office of Research and Development | 2023-01-31 |
| Methimazole in Patients With Progressive Glioblastoma (NCT05607407) | Case Comprehensive Cancer Center | 2023-01-30 |
| Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children (NCT05204550) | Murdoch Childrens Research Institute | 2023-01-30 |
| A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL (NCT05658562) | Tanabe Pharma Corporation | 2023-01-30 |
| A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours (NCT05508334) | RemeGen Co., Ltd. | 2023-01-30 |
| A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia (NCT04938154) | University of British Columbia | 2023-01-30 |
| Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC) (NCT04989218) | University of Alabama at Birmingham | 2023-01-30 |
| A Study of HB0025 Injection in Patients With Advanced Renal Cancer (NCT06222125) | Huabo Biopharm Co., Ltd. | 2023-01-30 |
| Study of Aerobic Training for People Receiving Treatment for Breast Cancer (NCT05716893) | Memorial Sloan Kettering Cancer Center | 2023-01-30 |
| Shortened Course Adjuvant Radiotherapy Following TORS (NCT05714657) | Abramson Cancer Center at Penn Medicine | 2023-01-30 |
| A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder (NCT05733546) | COMPASS Pathways | 2023-01-30 |
| Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer (NCT05481463) | Sun Yat-sen University | 2023-01-30 |